Victor Jeger, MD PhD’s Post

🌟 New Beginnings: Continuing my Journey in Medical Innovation and Serving Patients! 😊 It is with great pleasure and gratitude that I share my upcoming job change with you all! Starting from March 1st, 2025, I will be joining Roche Pharma Product Development Medical Affairs (PDMA) as the Therapeutic Area Head for Immunology. 👏 The past 6 years at Roche Diagnostics, especially the last 3.5 years as a Network Lead for Cardiometabolic Disease and Neurology in Clinical Development and Medical Affairs (CDMA) leadership, have flown by quickly. I am incredibly grateful for the personal connections, new friendships, and countless learning experiences. Moreover, I am immensely proud of all the teams I had the opportunity to work with, and I cherish all the successes and lessons we shared together. 🌍🧬 Together, we have been able to deliver life-changing products for patients suffering from various conditions such as Alzheimer's, heart failure, diabetes, preeclampsia, sepsis, and COVID-19, to name just a few. I take great pride in the diversity within our teams, our advisors, and the patients included in our studies. Inclusive research fosters robust science and benefits all our patients. 🚀🌟 I am excited to continue my personal learning journey alongside amazing colleagues at Roche Pharma. I look forward to forming new connections, collaborating with new teams, and delivering value to our patients. 🏢🇨🇭 The two pictures showcase the DIA campus in Rotkreuz and the Pharma campus in Basel, Switzerland. #NewBeginnings #GreatPlaceToWork #Roche #InclusiveResearch #Basel #PharmaInnovation #PatientCare